Skip to content
PeptideRank
altRx logo

Provider review

altRx cost: $299/mo tirzepatide

The featured "$89/mo" is a live promo — the real rate beside it is $199/mo.

altRx's own product page shows "Starting at $199/mo $89/mo" on the same card, and its own coupon-code system templates "$89/mo on your first month" — the lower figure is a dated, on-page promotion, not the standing rate.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What altRx discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Disclosed

Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit altRx

Pharmacy

503A pharmacy

Labs

Not stated.

States

Not stated

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Included

Shipping

Not confirmed

Lab work

Not disclosed

Coaching

Not disclosed

The catch — The featured "$89/$149" figures are a live, dated promotion ("OFFER ENDS AUGUST 5TH AT MIDNIGHT"), not the standing rate — the same product cards show the real "Starting at" price, $199/$299, struck through directly beside them, and altRx's own coupon-code system independently confirms the lower number is first-month-specific.

See plans at altRx

Prices read from altRx's own site · August 2026

What they advertise

altRx's own structured product data description and homepage banner state: "Compounded semaglutide from $89/mo, tirzepatide from $149/mo" — "SAME PRICE EVERY MONTH! STARTING at GLP-1: $89 | GLP-1 + GIP: $149. OFFER ENDS AUGUST 5TH AT MIDNIGHT!"

What you actually pay

The same product cards show a struck-through reference price directly beside the promo: "GLP-1 ... Starting at $199/mo $89/mo" and "GLP-1 + GIP ... Starting at $299/mo $149/mo" — and altRx's own coupon-code template literally reads, "$89/mo on your first month," confirming the lower figure is temporary.

Money you will meet later

  • altRx's own Terms of Service state that the checkout presents "a single total subscription price" inclusive of consultation and platform fees, rather than itemizing them separately.

The bottom line

altRx (altrx.com) sells compounded semaglutide and compounded tirzepatide, with a genuine company-wide 503A claim and a specific 48-hour cancellation window. Pricing is where it slips: the featured "$89/$149" figures sit beside struck-through "$199/$299" reference prices on the same product cards, and a sitewide banner ties the lower price to an explicit end date — this is a live promotion presented as if it were the everyday rate. Separately, FDA issued altRx's operating entity a warning letter (MARCS-CMS 728236, June 8, 2026, Center for Drug Evaluation and Research, addressed to "Trinity HealthCare Supply, LLC dba altRx"), independently re- at fda.gov, citing two violations found reviewing altrx.com in May 2026: the mislabeled-compounder claim already documented for several peers here ("altRx" pictured on the product label, suggesting altRx is the compounder when in fact it is not), plus a second, distinct citation — altRx's own marketing language ("GLP-1s are clinically proven medications…," "…clinically proven weight loss") is called false or misleading because it represents the compounded products as FDA-approved or otherwise evaluated for safety and effectiveness, when they have not been.

altRx appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want a company-wide, plain 503A claim stated directly in the Terms of Service.
  • A specific, dated cancellation window (48 hours before the next billing date) rather than a vague policy is what you're after.
  • You're comfortable paying the real "Starting at" rate ($199-299/mo) rather than expecting the promotional headline to hold.

Look elsewhere if

  • You're budgeting around the "$89/mo" or "$149/mo" headline figures — the same product cards show these struck through against $199/$299 as the "Starting at" reference rate.
  • You want a specific pharmacy named — altRx states only a company-wide category claim for its unnamed "pharmacy network."
  • Sermorelin is worth something to you — none appears anywhere on its site.

What altRx offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

503A pharmacy

altRx names the pharmacy that fills your prescription.

What its own site says

A company-wide, plain 503A claim with no single pharmacy named. Its own Terms of Service state directly, "Prescriptions are filled by independently owned and operated state-licensed 503A compounding pharmacies within the altRx pharmacy network."

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not stated

Not confirmed. Its own Terms of Service state only "licensed in your state of residence" — no explicit list of covered or excluded states was found.

The honest cons

The part they would rather you skipped

altRx's own product cards present a dated, live promotion ("$89/mo," ending on a specific stated date) directly beside the real "Starting at" reference rate ($199/mo) struck through on the same card — and its own coupon-code system independently confirms the lower figure applies to the first month only, not the standing rate a reader would actually pay from month two onward.

  • The real "Starting at" rate ($199/$299 per month) is more than double the featured promotional price shown first.
  • No specific pharmacy is named anywhere — only a company-wide category claim.
  • No explicit states-served or states-excluded list was found.
  • FDA warning letter (MARCS-CMS 728236, June 8, 2026, addressed to Trinity HealthCare Supply, LLC dba altRx) for a mislabeled-compounder claim plus marketing language ("clinically proven") FDA found represents its compounded products as FDA-approved, when they are not.

None of this is unique to altRx — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.

Ready to get started?

Prices and plans in this category change often — check altRx's current pricing before you decide. Ours was read from their own site in August 2026.

See altRx pricing

Facts on this page reflect altRx's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on altRx's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.

altRx

2 compounds from $199/mo

Visit